Coronavirus Stocks: Pfizer, BioNTech, Mesoblast
Australian biotech Mesoblast (MESO) rocketed 17% on earnings, and on a Covid-19 treatment partnership with Switzerland's Novartis (NVS). Volatile Mesoblast shares have a 60% year-to-date gain, but are down 44% from a late-August high.
This came out tonight on the US Investor business Daily.
Watch this space.
- Forums
- ASX - By Stock
- Ann: Novartis and Mesoblast Remestemcel-L Collaboration
Coronavirus Stocks: Pfizer, BioNTech, MesoblastAustralian...
-
- There are more pages in this discussion • 450 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.46 |
Change
0.075(5.42%) |
Mkt cap ! $1.587B |
Open | High | Low | Value | Volume |
$1.39 | $1.50 | $1.38 | $4.434M | 3.079M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 16229 | $1.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.46 | 34429 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 12905 | 1.455 |
9 | 32015 | 1.450 |
6 | 62611 | 1.445 |
8 | 98670 | 1.440 |
4 | 27648 | 1.435 |
Price($) | Vol. | No. |
---|---|---|
1.460 | 43768 | 7 |
1.465 | 70651 | 9 |
1.470 | 143903 | 9 |
1.475 | 30368 | 6 |
1.480 | 8159 | 3 |
Last trade - 13.33pm 11/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online